Besifloxacin is a prescription fluoroquinolone antibiotic formulated as an ophthalmic suspension to treat bacterial eye infections. To support the rigorous demands of pharmaceutical development, this category… Read more














Besifloxacin is a prescription fluoroquinolone antibiotic formulated as an ophthalmic suspension to treat bacterial eye infections. To support the rigorous demands of pharmaceutical development, this category provides a comprehensive selection of reference standards, including the active pharmaceutical ingredient, its related impurities, and synthetic intermediates. Analytical laboratories utilize these compounds to conduct precise impurity profiling, method validation, and ongoing quality control. By incorporating pharmacopeial and non-pharmacopeial impurities, alongside specific enantiomers and stable isotope-labelled compounds, researchers can ensure the accurate identification and quantification of degradation products or synthetic byproducts. These high-quality standards are essential for maintaining compliance with regulatory benchmarks throughout the drug development and manufacturing lifecycle of this ophthalmic agent.